Laura Venerandi

922 total citations
16 papers, 578 citations indexed

About

Laura Venerandi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Laura Venerandi has authored 16 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 6 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Laura Venerandi's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (3 papers). Laura Venerandi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (3 papers). Laura Venerandi collaborates with scholars based in Italy, Romania and Gambia. Laura Venerandi's co-authors include Fabio Piscaglia, Luigi Bolondi, Sara Marinelli, Marzia Galassi, Rita Golfieri, Alessandro Granito, Angelo Sangiovanni, Maddalena Milazzo, S. Vavassori and Massimo Iavarone and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Hepatology.

In The Last Decade

Laura Venerandi

14 papers receiving 563 citations

Peers

Laura Venerandi

HEPAT

EPIDE

SURGE

Chen‐Chun Lin Taiwan

Marzia Galassi Italy

Kambiz Kosari United States

Wen-Yen Huang Taiwan

Zhongyang Shen China

Alessandra R. Garcia United States

Naoya Kanogawa Japan

Yu Sawada Japan

Young Hwa Chung South Korea

Jacopo Lera Italy

Chen‐Chun Lin Taiwan

Laura Venerandi

372 ×1.3

HEPAT

216 ×1.1

EPIDE

167 ×1.1

SURGE

80 ×0.6

89 ×0.6

Citations per year, relative to Laura Venerandi Laura Venerandi (= 1×) peers Chen‐Chun Lin

Countries citing papers authored by Laura Venerandi

Since Specialization

Citations

This map shows the geographic impact of Laura Venerandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Venerandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Venerandi more than expected).

Fields of papers citing papers by Laura Venerandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Venerandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Venerandi. The network helps show where Laura Venerandi may publish in the future.

Co-authorship network of co-authors of Laura Venerandi

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Venerandi. A scholar is included among the top collaborators of Laura Venerandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Venerandi. Laura Venerandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Fornari, Francesca, Manuela Ferracin, Davide Treré, et al.. (2015). Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC. PLoS ONE. 10(10). e0141448–e0141448. 124 indexed citations

Granito, Alessandro, Sara Marinelli, Eleonora Terzi, et al.. (2015). Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure. Digestive and Liver Disease. 47(6). 518–522. 71 indexed citations

Toaldo, Marco Baron, Veronica Salvatore, Sara Marinelli, et al.. (2014). Use of VEGFR-2 Targeted Ultrasound Contrast Agent for the Early Evaluation of Response to Sorafenib in a Mouse Model of Hepatocellular Carcinoma. Molecular Imaging and Biology. 17(1). 29–37. 49 indexed citations

Terzi, Eleonora, Laura Venerandi, Matteo Renzulli, et al.. (2014). The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series. Digestive Diseases. 32(6). 711–716. 45 indexed citations

Marinelli, Sara, Veronica Salvatore, Marco Baron Toaldo, et al.. (2014). Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma. BMC Cancer. 14(1). 403–403. 7 indexed citations

Piscaglia, Fabio, Sara Marinelli, Simona Bota, et al.. (2013). The role of ultrasound elastographic techniques in chronic liver disease: Current status and future perspectives. European Journal of Radiology. 83(3). 450–455. 54 indexed citations

Cucchetti, Alessandro, Fabio Piscaglia, Matteo Cescon, et al.. (2013). An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. Digestive and Liver Disease. 46(3). 257–263. 30 indexed citations

Iavarone, Massimo, Fabio Piscaglia, S. Vavassori, et al.. (2013). Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. Journal of Hepatology. 58(6). 1188–1193. 92 indexed citations

Galassi, Marzia, Massimo Iavarone, Sandro Rossi, et al.. (2013). Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound. Liver International. 33(5). 771–779. 87 indexed citations

10.

Marinelli, Sara, Alessandro Granito, Eleonora Terzi, et al.. (2013). Clinical predictors of response to sorafenib in patients with hepatocellular carcinoma.. Journal of Clinical Oncology. 31(15_suppl). e15149–e15149. 1 indexed citations

11.

Piscaglia, Fabio, Anna Pecorelli, Laura Venerandi, et al.. (2013). 109 CLINICAL VALIDATION OF A SUB-STAGING PROPOSAL OF PATIENTS WITH INTERMEDIATE HCC (BCLC-B). Journal of Hepatology. 58. S48–S49. 8 indexed citations

12.

Marinelli, Sara, Veronica Salvatore, Marco Baron Toaldo, et al.. (2013). Evaluation of efficacy of antiangiogenic treatment using US-based techniques in a murine model of hepatocellular carcinoma (HCC) under different treatment schedule. Ultraschall in der Medizin - European Journal of Ultrasound. 34(S 01).

13.

Pecorelli, Anna, Fabio Piscaglia, Laura Venerandi, et al.. (2013). OC-15 Clinical validation of a sub-staging proposal of patients with intermediate HCC (BCLC-B). Digestive and Liver Disease. 45. S5–S6. 1 indexed citations

14.

Salvatore, Veronica, Marco Baron Toaldo, Sara Marinelli, et al.. (2013). Early Prediction of Treatment Response to Sorafenib with Elastosonography in a Mice Xenograft Model of Hepatocellular Carcinoma: A Proof-of-Concept Study. Ultraschall in der Medizin - European Journal of Ultrasound. 34(6). 541–549. 5 indexed citations

15.

Borghi, Alessandro, Fabio Piscaglia, Laura Venerandi, et al.. (2012). 614 SPLENIC STIFFNESS ASSESSED BY ARFI (ACOUSTIC RADIATION FORCE IMAGING) CORRELATES WITH PORTAL PRESSURE IN CIRRHOSIS. Journal of Hepatology. 56. S243–S244. 4 indexed citations

16.

Borghi, Alessandro, Laura Venerandi, Veronica Salvatore, et al.. (2012). T-23 Splenic stiffness assessed by ARFI (acoustic radiation force impulse) correlates with portal pressure in liver cirrhosis. Digestive and Liver Disease. 44. S21–S22.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact